Cancer Center at Illinois (CCIL) Program Leader Brian Cunningham has developed two new biomarker detection instruments with the potential to transform point-of-care diagnostics. In collaboration with researchers and clinicians at Stanford, Mayo Clinic, and Huntsman Cancer Institute, the Cunningham lab’s new instruments can vividly and rapidly detect a variety of cancer biomarkers using a novel gold nanoparticle […]